.png)
%20(png).png)
%20(png).png){kind=small}
Module BI: "Bio-Innovation - Basic principles of entrepreneurship and innovation / Intellectual property and exploitation of results"
The Courses cover the Basic Principles of Technology Transfer & IP Protection, their Legal Aspects, and the Commercialization in the Biotechnology Sector. They will also introduce the students to the principles of Innovation and Entrepreneurship, the Innovation Process, the Development of New Products & Services, Business Planning & Business Finance, the Start-ups, the Knowledge-Intensive Enterprises/Spin-offs & Venture Capital and the Innovation & Entrepreneurship in the Global Economy.
Coordinators:
Michalis STANGOS (MSCOMM and Industry Disruptors-Game Changers)
Innovator and Entrepreneur
Founder and Chief Executive Officer (CEO) of MSCOMM AE
Founder of Industry Disruptors - Game Changers (ID-GC)
Managing Director at Global Entrepreneurship Network (GEN)
George KOLLIAS (National and Kapodistrian University of Athens, Medical School) - MSc Director
Professor of Physiology – Member of the Academy of Athens
Department of Physiology, Medical School, National and Kapodistrian University of Athens
Associate Researcher – Group Leader – Biomedical Sciences Research Center (BSRC) “Alexander Fleming”
EMBO Member
Lecturers:
​Efthimios SKOULAKIS (BSRC Alexander Fleming)
Deputy Director of the Institute for Fundamental Biomedical Research of BSRC "Alexander Fleming"
Researcher A' – Professor level – Group Leader
Neuronal function and dysfunction Group
Biomedical Sciences Research Center (BSRC) “Alexander Fleming”
Athina IKONOMIDOU (Hellenic Pasteur Institute, ResQ Biotech)
​Life Sciences Business Development Manager - Tech Transfer Expert
Co-founder and Business Development Manager at ResQ Biotech
Member Board of Directors at Hellenic Pasteur Institute
Kay MARTIN (BSRC Alexander Fleming)​
Administrator of the Technology Transfer Office
Innovation & Enterprise Unit
Biomedical Sciences Research Center (BSRC) “Alexander Fleming”
Georgios SKRETAS (ResQ Biotech, BSRC Alexander Fleming)​
Chief Executive Officer & Chief Scientific Officer, ResQ Biotech
Researcher A' – Professor level – Group Leader, Director Institute for Bio-innovation
Biomedical Sciences Research Center “Alexander Fleming”
Katia KARALIS (Regeneron Pharmaceuticals, Inc.)​
Affiliated Investigator – Biomedical Research Foundation of the Academy of Athens
Executive Director Research and Development,
Head of Human Systems for Disease Modeling and Drug Development
Regeneron Pharmaceticals Inc., ΝΥ
Takis ZERVAKAKIS (ILS Pharma)​
Chief Executive Officer (CEO) at Innovation in Life Sciences Pharma L.P.
Former Senior Executive at ex-Wyeth/Pfizer Hellas
Former General Manager at InClinica and Vice-President Business Development & Marketing of ZeinCRO Group
Former Vice-President of the Hellenic Association of Pharmaceutical Companies (SFEE, 1998-2009)
Ioannis KATSAROLIS (Gilead Sciences)​
Director, Medical Affairs,
Gilead Sciences Hellas, Cyprus & European Distributor Markets
Virology Medical Affairs for European Distributor Markets Department (HIV, Liver Diseases and COVID-19)
